Pharma Journalist -

In recent years, big health has risen as a national policy of China with the introduction of the “Healthy China 2030” Planning Outline, and China has specified the new positioning of…
Read More...

Animal Health & Feed Zone of CPhI China 2019 to Build a New Benchmark for the Industry Size of the global veterinary drug market continues to grow as the market continues to…
Read More...

As the race for the first FDA-approved microbiome-based therapeutic continues, join the 4th Microbiome Movement – Drug Development Summit this June to hear directly from 5 key industry…
Read More...

Abbott and Novo Nordisk announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital…
Read More...

Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for ESPEROCT for the treatment of adults and children with…
Read More...

Xencor, Inc. announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its Phase 1 study of XmAb14045, a CD123 x CD3 bispecific antibody molecule…
Read More...

Merck announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck’s patent application directed to its proxy-CRISPR technology. “This is…
Read More...

Morphic Therapeutic announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janssen) to discover and develop novel integrin therapeutics…
Read More...

Pharmaceutical Microbiology West Coast is back after a successful launch event in 2018. This year the conference is taking place at the Hyatt Regency Mission Bay Hotel, CA, USA on June…
Read More...

QIAGEN N.V. announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V., to develop innovative bioinformatics and assay solutions to accelerate research targeting the…
Read More...